Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3738631013 | Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3738632018 | Product containing only bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | a pour principe actif (attribut) | Metronidazole (substance) | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | a pour principe actif (attribut) | Tetracycline (substance) | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | est un(e) (attribut) | Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | est un(e) (attribut) | Product containing only bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) | true | Inferred relationship | Some | ||
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | a pour principe actif (attribut) | biskalcitrate de bismuth | true | Inferred relationship | Some | 3 | |
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | False | Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | Inferred relationship | Some | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | est un(e) (attribut) | True | Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets